US Insurer Spending on Ivermectin Prescriptions for COVID-19
Kao‐Ping Chua, Rena M. Conti, Nora V. Becker
Abstract
comorbidities, fewer hospitalizations and respiratory diagnoses, and a decrease in severity and mortality.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)HumanitiesMedical prescriptionInternal medicineNursingArtDiseaseInfectious disease (medical specialty)Healthcare cost, quality, practicesHealth Systems, Economic Evaluations, Quality of LifeClimate Change and Health Impacts